Maravai LifeSciences Inc... (MRVI)
NASDAQ: MRVI
· Real-Time Price · USD
2.62
0.02 (0.77%)
At close: Aug 15, 2025, 3:59 PM
2.62
0.19%
After-hours: Aug 15, 2025, 06:49 PM EDT
Maravai LifeSciences Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 269.91M | 285.05M | 322.4M | 578.16M | 573.17M | 561.69M | 574.96M | 579.61M | 580.18M | 628.27M | 632.14M | 617.45M | 550.68M | 431.47M | 551.27M | 547.9M | 374.71M | 247.68M |
Short-Term Investments | n/a | n/a | n/a | n/a | 6.58M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | 8.1M | 8.56M | 13.27M | 13.98M | 9.99M | 11.36M | 10.37M | 5.41M | 3.71M | 541K | n/a | n/a | n/a |
Other Long-Term Assets | 51.98M | 57.58M | 7.24M | 60.91M | 63.47M | 66.88M | -211.67M | 9.45M | 13.74M | 117.04M | 40.33M | 12.18M | 10.22M | 60.53M | 52.91M | 4.11M | 4.03M | 4.3M |
Receivables | 27.88M | 28.49M | 38.52M | 28.87M | 39.26M | 39.53M | 55.72M | 49.2M | 49.22M | 56.89M | 146.81M | 114.07M | 128.93M | 120.36M | 117.51M | 65.94M | 83.53M | 121.82M |
Inventory | 46.67M | 49.77M | 50.08M | 50.41M | 49.29M | 49.85M | 51.4M | 49.14M | 47.4M | 54.82M | 43.15M | 62.42M | 60.11M | 51.41M | 51.56M | 56.25M | 47.78M | 47.13M |
Other Current Assets | 15.3M | 12.96M | 18.14M | 21.66M | 23.64M | 16.82M | 17.83M | 22.92M | 22.52M | 25.53M | 25.8M | 18.16M | n/a | n/a | 19.7M | n/a | 125.03M | n/a |
Total Current Assets | 359.76M | 376.28M | 429.15M | 679.1M | 685.36M | 667.88M | 699.91M | 700.87M | 699.31M | 765.51M | 847.9M | 835.53M | 759.38M | 619.13M | 740.04M | 687.48M | 644.49M | 425.54M |
Property-Plant & Equipment | 162.73M | 166.43M | 217.03M | 164.56M | 165.5M | 161.63M | 222.65M | 216.42M | 206.63M | 87.72M | 116.59M | 113.27M | 103.75M | 47.7M | 46.33M | 108.32M | 104.75M | 105.13M |
Goodwill & Intangibles | 322.5M | 359.46M | 354.83M | 373.65M | 533.28M | 540.15M | 547.02M | 553.88M | 561.18M | 568.15M | 500.33M | 506.43M | 512.69M | 518.94M | 270.34M | 273.99M | 277.88M | 396.89M |
Total Long-Term Assets | 537.21M | 583.47M | 579.1M | 599.12M | 762.25M | 776.76M | 787.54M | 1.57B | 1.57B | 1.55B | 1.43B | 1.41B | 1.41B | 1.42B | 1.18B | 1.21B | 956.76M | 926.23M |
Total Assets | 896.97M | 959.75M | 1.01B | 1.28B | 1.45B | 1.44B | 1.49B | 2.27B | 2.26B | 2.32B | 2.28B | 2.25B | 2.17B | 2.04B | 1.92B | 1.89B | 1.6B | 1.35B |
Account Payables | 11.53M | 9.53M | 11.96M | 9.49M | 12.54M | 8.23M | 10.73M | 9.42M | 6.66M | 4.78M | 5.99M | 9.46M | 23.27M | 10.38M | 8.15M | 8.92M | 11.7M | 9.81M |
Deferred Revenue | 1.64M | 2.76M | 3.29M | 1.83M | 3.49M | 4.18M | 3.36M | 2.55M | 2.46M | 2.05M | 3.09M | 5.82M | 5.43M | 3.69M | 10.21M | 66.72M | 109.49M | 119.17M |
Short-Term Debt | 6.32M | 5.44M | 5.44M | 5.44M | 5.44M | 5.44M | 5.44M | 5.44M | 5.44M | 5.44M | 5.44M | 5.44M | 5.44M | 5.44M | 6M | 6M | 6M | 6M |
Other Current Liabilities | 61.73M | n/a | n/a | 23.62M | 12.94M | 9.17M | 47.62M | n/a | n/a | 84.68M | 69.48M | 72.78M | 60.89M | 34.75M | 46.8M | 10.11M | 30.4M | n/a |
Total Current Liabilities | 69.68M | 63.16M | 56.97M | 63.24M | 68.55M | 59.02M | 87.47M | 78.25M | 74.92M | 124.9M | 110.14M | 115.66M | 112.53M | 86.67M | 93.78M | 114.35M | 164.77M | 165.25M |
Long-Term Debt | 30.65M | 289.5M | 290.49M | 516.28M | 517.08M | 517.89M | 518.71M | 519.52M | 520.34M | 537.73M | 522M | 522.82M | 523.65M | 524.5M | 524.59M | 525.58M | 526.58M | 527.59M |
Other Long-Term Liabilities | 326.62M | 2.28M | 11.09M | 54.24M | 54.03M | 58.62M | 11.98M | 688.78M | 679.02M | 673.3M | 693.38M | 768.75M | 761.82M | 711.23M | 713.64M | 745.81M | 521.12M | 384.67M |
Total Long-Term Liabilities | 359.3M | 366.32M | 374.06M | 601.85M | 602.64M | 608.23M | 610.1M | 1.3B | 1.29B | 1.29B | 1.27B | 1.29B | 1.29B | 1.3B | 1.28B | 1.33B | 1.1B | 976.76M |
Total Liabilities | 428.98M | 429.48M | 431.04M | 665.09M | 671.19M | 667.25M | 697.57M | 1.38B | 1.37B | 1.41B | 1.38B | 1.41B | 1.4B | 1.39B | 1.37B | 1.44B | 1.27B | 1.14B |
Total Debt | 36.97M | 370.62M | 376.69M | 561.08M | 561.88M | 562.69M | 610.97M | 614.68M | 617.27M | 616.27M | 585.26M | 534.1M | 533.41M | 529.94M | 534.31M | 586.91M | 588.21M | 589.52M |
Common Stock | 2.55M | 2.55M | 2.53M | 2.52M | 2.52M | 2.52M | 2.51M | 2.51M | 2.51M | 2.51M | 2.55M | 2.55M | 2.55M | 2.55M | 2.55M | 2.58M | 2.58M | 2.58M |
Retained Earnings | 71.36M | 110.95M | 140.89M | 167.04M | 266.07M | 273.66M | 285.74M | 391.7M | 398.16M | 404.7M | 404.77M | 367.13M | 322.66M | 251.42M | 184.56M | 127.45M | 73.18M | 24.1M |
Comprehensive Income | 574K | 324K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | -0.00 | n/a | n/a | n/a | n/a | -0.00 | -39K | -42K |
Shareholders Equity | 265.86M | 300.61M | 325.29M | 345.14M | 436.93M | 410.66M | 416.75M | 519.29M | 520.57M | 521.52M | 545.22M | 503.76M | 456.59M | 382.56M | 315.5M | 302.64M | 193.92M | 112.61M |
Total Investments | n/a | n/a | n/a | n/a | 6.58M | 8.1M | 8.56M | 13.27M | 13.98M | 9.99M | 11.36M | 10.37M | 5.41M | 3.71M | 541K | n/a | n/a | n/a |